• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

假定的肿瘤抑制因子微小RNA-30a-5p通过抑制ZEB2来调节肾透明细胞癌的侵袭性。

The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.

作者信息

Chen Zhenhua, Zhang Jiaxing, Zhang Zhiling, Feng Zihao, Wei Jinhuan, Lu Jun, Fang Yong, Liang Yanping, Cen Junjie, Pan Yihui, Huang Yong, Zhou Fangjian, Chen Wei, Luo Junhang

机构信息

Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

出版信息

Cell Death Dis. 2017 Jun 1;8(6):e2859. doi: 10.1038/cddis.2017.252.

DOI:10.1038/cddis.2017.252
PMID:28569782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5520909/
Abstract

Clear cell renal cell carcinoma (ccRCC), the most common subtype of renal cell carcinoma, can easily invade local tissues and metastasize, and is resistant to currently available treatments. Recent studies profiling microRNA expression in ccRCC have suggested miR-30a-5p may be deregulated in these cancer cells. To determine its role and mechanism of action in ccRCC, miR-30-5p expression levels were quantified and functions were analyzed using in vitro and in vivo experiments and bioinformatics. A decrease in miR-30a-5p expression was frequently noted in ccRCC cells and tissues. Importantly, low miR-30a-5p levels were significantly associated with a poor ccRCC patient prognosis. Stable overexpression of miR-30a-5p in 769-P cells was sufficient to prevent cellular proliferation and invasion in vitro and in vivo. Upon further examination, it was found that miR-30a-5p directly targeted the 3'-UTR of ZEB2 and suppressed ccRCC cell epithelial-mesenchymal transition. In addition, miR-30a-5p may be downregulated by the long non-coding RNA DLEU2. Taken together, these data reveal an important role for miR-30a-5p in the regulation of ccRCC proliferation and invasion, and indicate the potential for miR-30a-5p in applications furthering ccRCC prognostics and therapeutics.

摘要

透明细胞肾细胞癌(ccRCC)是肾细胞癌最常见的亚型,极易侵犯局部组织并发生转移,且对目前可用的治疗方法具有抗性。最近对ccRCC中微小RNA表达进行分析的研究表明,miR-30a-5p在这些癌细胞中可能表达失调。为了确定其在ccRCC中的作用和作用机制,通过体外和体内实验以及生物信息学对miR-30-5p的表达水平进行了定量分析,并对其功能进行了分析。在ccRCC细胞和组织中经常发现miR-30a-5p表达降低。重要的是,低水平的miR-30a-5p与ccRCC患者的不良预后显著相关。在769-P细胞中稳定过表达miR-30a-5p足以在体外和体内抑制细胞增殖和侵袭。进一步研究发现,miR-30a-5p直接靶向ZEB2的3'-UTR并抑制ccRCC细胞的上皮-间质转化。此外,miR-30a-5p可能被长链非编码RNA DLEU2下调。综上所述,这些数据揭示了miR-30a-5p在调节ccRCC增殖和侵袭中的重要作用,并表明miR-30a-5p在改善ccRCC预后和治疗方面的应用潜力

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/df187e323465/cddis2017252f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/808bf4bd7b98/cddis2017252f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/c23a6e8bb9e5/cddis2017252f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/3245d5a0fc76/cddis2017252f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/28721c7a406e/cddis2017252f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/47a4e1e6e5c1/cddis2017252f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/df187e323465/cddis2017252f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/808bf4bd7b98/cddis2017252f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/c23a6e8bb9e5/cddis2017252f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/3245d5a0fc76/cddis2017252f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/28721c7a406e/cddis2017252f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/47a4e1e6e5c1/cddis2017252f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/5520909/df187e323465/cddis2017252f6.jpg

相似文献

1
The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.假定的肿瘤抑制因子微小RNA-30a-5p通过抑制ZEB2来调节肾透明细胞癌的侵袭性。
Cell Death Dis. 2017 Jun 1;8(6):e2859. doi: 10.1038/cddis.2017.252.
2
MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.微小RNA-30a-5p通过调节GRP78表达抑制肾细胞癌的生长。
Cell Physiol Biochem. 2017;43(6):2405-2419. doi: 10.1159/000484394. Epub 2017 Oct 27.
3
MiR-30a suppresses clear cell renal cell carcinoma proliferation and metastasis by targeting LRP6.miR-30a 通过靶向 LRP6 抑制肾透明细胞癌细胞的增殖和转移。
Hum Cell. 2021 Mar;34(2):598-606. doi: 10.1007/s13577-020-00472-1. Epub 2021 Jan 5.
4
The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.Lnc LINC00461/miR-30a-5p 通过调节 ZEB2 促进非小细胞肺癌的进展和恶性转化。
Cell Cycle. 2020 Apr;19(7):825-836. doi: 10.1080/15384101.2020.1731946. Epub 2020 Feb 27.
5
The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.长链非编码 RNA SNHG5 通过靶向 ZEB1 下调 miR-205-5p 促进肾透明细胞癌的进展。
Cancer Med. 2020 Jun;9(12):4251-4264. doi: 10.1002/cam4.3052. Epub 2020 Apr 12.
6
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.表观遗传调控的 miR-30a/c-5p 可直接靶向 TWIST1 并抑制 ccRCC 细胞的侵袭能力。
Transl Res. 2022 Nov;249:110-127. doi: 10.1016/j.trsl.2022.06.009. Epub 2022 Jun 11.
7
SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.SNHG12 通过作为竞争性内源性 RNA 和海绵吸附 miR-30a-3p 促进人肾细胞癌的发生。
J Cell Mol Med. 2021 May;25(10):4696-4708. doi: 10.1111/jcmm.16417. Epub 2021 Mar 30.
8
Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.利用 miR-32-5p 抑制透明细胞肾细胞癌转移的临床前研究:通过改变 miR-32-5p/TR4/HGF/Met 信号。
Int J Cancer. 2018 Jul 1;143(1):100-112. doi: 10.1002/ijc.31289. Epub 2018 Apr 2.
9
serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma.在透明细胞肾细胞癌中作为一种新型生物标志物,通过吸附miR-204-5p和上调RAB22A来促进肿瘤进展。
Ann Med. 2021 Dec;53(1):2153-2164. doi: 10.1080/07853890.2021.2001563.
10
Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.ACHN 细胞来源的外泌体 microRNA-15a 通过 BTG2/PI3K/AKT 轴加重肾透明细胞癌。
Kaohsiung J Med Sci. 2021 Nov;37(11):973-982. doi: 10.1002/kjm2.12428. Epub 2021 Aug 1.

引用本文的文献

1
Non-coding transcriptome profiles in clear-cell renal cell carcinoma.透明细胞肾细胞癌中的非编码转录组图谱
Nat Rev Urol. 2025 Mar;22(3):151-174. doi: 10.1038/s41585-024-00926-3. Epub 2024 Sep 6.
2
Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study.透明细胞肾细胞癌的诊断、预测和预后分子标志物:一项回顾性研究。
Cancer Rep (Hoboken). 2024 Jun;7(6):e2116. doi: 10.1002/cnr2.2116.
3
Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis.

本文引用的文献

1
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.微小RNA-30a-5p的过表达通过靶向MTDH/PTEN/AKT通路抑制肝癌细胞增殖并诱导其凋亡。
Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.
3
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
载脂蛋白L1是透明细胞肾细胞癌转移中的一种肿瘤抑制因子。
Front Oncol. 2024 Apr 12;14:1371934. doi: 10.3389/fonc.2024.1371934. eCollection 2024.
4
Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer.淋巴细胞白血病 2 号缺失(DLEU2):一种有希望成为癌症未来诊断和治疗的生物标志物。
Clin Transl Oncol. 2023 Oct;25(10):2772-2782. doi: 10.1007/s12094-023-03149-x. Epub 2023 Apr 24.
5
Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application.液体活检在肾细胞癌前沿的应用:技术分析与临床应用的最新进展。
Mol Cancer. 2023 Feb 21;22(1):37. doi: 10.1186/s12943-023-01745-7.
6
A review on the role of long non-coding RNA and microRNA network in clear cell renal cell carcinoma and its tumor microenvironment.长链非编码RNA与微小RNA网络在肾透明细胞癌及其肿瘤微环境中的作用综述
Cancer Cell Int. 2023 Feb 2;23(1):16. doi: 10.1186/s12935-023-02861-6.
7
miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways.微小RNA-30a通过细胞外调节蛋白激酶(ERK)、蛋白激酶B(AKT)和p38信号通路靶向STOX2,以增加葡萄胎中的细胞增殖和转移。
Cancer Cell Int. 2022 Mar 4;22(1):103. doi: 10.1186/s12935-022-02503-3.
8
Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.长链非编码RNA DLEU2在肾透明细胞癌和肝细胞癌中的预后价值及其与免疫浸润的关系
Int J Gen Med. 2021 Nov 11;14:8047-8064. doi: 10.2147/IJGM.S336428. eCollection 2021.
9
ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma.ANLN 受 miR-30a-5p 调控,介导肺腺癌的恶性进展。
Comput Math Methods Med. 2021 Nov 5;2021:9549287. doi: 10.1155/2021/9549287. eCollection 2021.
10
N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.与透明细胞肾细胞癌预后和免疫治疗疗效相关的N6-甲基腺苷相关长链非编码RNA特征
Front Genet. 2021 Oct 15;12:726369. doi: 10.3389/fgene.2021.726369. eCollection 2021.
长链非编码RNA MALAT1作为一种竞争性内源性RNA,通过在透明细胞肾癌中吸附miR-200s来调节ZEB2的表达。
Oncotarget. 2015 Nov 10;6(35):38005-15. doi: 10.18632/oncotarget.5357.
4
miRWalk2.0: a comprehensive atlas of microRNA-target interactions.miRWalk2.0:一个全面的微小RNA-靶标相互作用图谱。
Nat Methods. 2015 Aug;12(8):697. doi: 10.1038/nmeth.3485.
5
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.TANRIC:一个用于探索长链非编码RNA在癌症中功能的交互式开放平台。
Cancer Res. 2015 Sep 15;75(18):3728-37. doi: 10.1158/0008-5472.CAN-15-0273. Epub 2015 Jul 24.
6
miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.微小RNA-靶标网络揭示了miR-124通过靶向CAV1和FLOT1成为促进肾透明细胞癌侵袭行为的关键微小RNA。
Oncotarget. 2015 May 20;6(14):12543-57. doi: 10.18632/oncotarget.3815.
7
miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.miR-141 通过调控 EphA2 的表达来调控肾细胞癌的增殖和转移。
Clin Cancer Res. 2014 May 15;20(10):2617-30. doi: 10.1158/1078-0432.CCR-13-3224. Epub 2014 Mar 19.
8
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.starBase v2.0:从大规模 CLIP-Seq 数据中解码 miRNA-ceRNA、miRNA-ncRNA 和蛋白质-RNA 相互作用网络。
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7. doi: 10.1093/nar/gkt1248. Epub 2013 Dec 1.
9
The imprinted H19 lncRNA antagonizes let-7 microRNAs.印记的 H19 lncRNA 拮抗 let-7 微 RNA。
Mol Cell. 2013 Oct 10;52(1):101-12. doi: 10.1016/j.molcel.2013.08.027. Epub 2013 Sep 19.
10
Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.肾细胞癌中 ZEB2 的蛋白表达及其对患者生存预后的意义。
PLoS One. 2013 May 2;8(5):e62558. doi: 10.1371/journal.pone.0062558. Print 2013.